It's Confirmed, We Know What Really Scares the Dems in 2026
Here's the Bar Owners’ Lawsuit Against Roy Cooper That Could Play a Role...
Cities Are Giving Up on Flock Safety Cameras
'Annoying, Bitter Old Man': Journey Keyboardist Slams Bruce Springsteen for Politicizing M...
James Talarico Fought to Expose Kids to Inappropriate LGBTQ Books
Do Teachers Unions Actually Care About Teaching Anymore?
From Swalwell to Gallego to Gray: Democrats’ Slush Fund Scandal Spreads
NBC News Blames Idaho Laws for Death of Trans Teen
James Talarico Laments That Texas Didn't Pass the George Floyd Act
Rep. Lisa McClain Sounds the Alarm on Communism’s Return to American Politics
Exploitation Isn't a Free Market Problem. It's a Government One.
Disney Guts Pixar, ESPN in Third Round of Layoffs This Year
Some Cubans May Finally Get Humanitarian Aid As Communist Leaders Rail Against U.S.
Trump Reveals 'We've Been Nice' to Iran – Leaving Door Open for Heightened...
The Smithsonian National Museum of American History Had a Disastrous Hearing on the...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos